前列腺癌中 DNA 修复途径的异常——最新进展。
Aberrations of DNA Repair Pathways in Prostate Cancer-The State of the Art.
机构信息
Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, UK.
Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
出版信息
Int J Mol Sci. 2023 Feb 21;24(5):4301. doi: 10.3390/ijms24054301.
Abstract
Prostate cancer (PC) is the second most commonly diagnosed cancer in males worldwide and the fifth most common cause of cancer-related death in men [...].
摘要
前列腺癌（PC）是全球男性中第二大常见的癌症，也是男性癌症相关死亡的第五大主要原因[... ]。
相似文献
1
Aberrations of DNA Repair Pathways in Prostate Cancer-The State of the Art.前列腺癌中 DNA 修复途径的异常——最新进展。
Int J Mol Sci. 2023 Feb 21;24(5):4301. doi: 10.3390/ijms24054301.
2
Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic.前列腺癌中 DNA 修复途径的遗传异常：向临床转化。
Int J Mol Sci. 2021 Sep 10;22(18):9783. doi: 10.3390/ijms22189783.
3
DNA Repair in Prostate Cancer: Biology and Clinical Implications.前列腺癌中的 DNA 修复：生物学与临床意义。
Eur Urol. 2017 Mar;71(3):417-425. doi: 10.1016/j.eururo.2016.08.037. Epub 2016 Aug 31.
4
Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.前列腺癌细胞DNA损伤后DNA链断裂修复缺陷：对基因不稳定和前列腺癌进展的影响。
Cancer Res. 2004 Dec 1;64(23):8526-33. doi: 10.1158/0008-5472.CAN-04-1601.
5
DNA methylation in promoter region as biomarkers in prostate cancer.启动子区域的DNA甲基化作为前列腺癌的生物标志物
Methods Mol Biol. 2012;863:67-109. doi: 10.1007/978-1-61779-612-8_5.
6
Promoter hypermethylation in prostate cancer.前列腺癌中的启动子高甲基化。
Cancer Control. 2010 Oct;17(4):245-55. doi: 10.1177/107327481001700405.
7
Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology.前列腺癌中DNA修复途径的畸变：精准肿瘤学的基石。
Expert Opin Ther Targets. 2021 May;25(5):329-333. doi: 10.1080/14728222.2021.1951226. Epub 2021 Jul 8.
8
Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations.患有代谢异常的男性中的前列腺癌、前列腺癌死亡以及其他原因导致的死亡。
Epidemiology. 2014 Nov;25(6):823-8. doi: 10.1097/EDE.0000000000000174.
9
PARP inhibition in prostate cancer.前列腺癌的聚腺苷二磷酸核糖聚合酶抑制作用。
Genes Chromosomes Cancer. 2021 May;60(5):344-351. doi: 10.1002/gcc.22903. Epub 2020 Oct 28.
10
DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population.DNA 修复基因多态性（XPG 和 XRCC1）与北印度人群前列腺癌的关联。
Mol Biol Rep. 2012 Mar;39(3):2471-9. doi: 10.1007/s11033-011-0998-5. Epub 2011 Jun 14.
本文引用的文献
1
Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin.生长抑素、皮质抑素及其受体在雄激素非依赖性前列腺癌细胞中发挥抗肿瘤作用：内源性皮质抑素的关键作用。
Int J Mol Sci. 2022 Oct 27;23(21):13003. doi: 10.3390/ijms232113003.
2
BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.卵巢癌和前列腺癌中的BRCA突变：从 bench 到 bedside。 （注：bench 到 bedside 可理解为从基础研究到临床应用，这里直接保留英文以便更准确传达原文语境）
Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888.
3
Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer.PARP 和免疫检查点抑制剂在卵巢上皮性癌中的最新研究进展
Int J Environ Res Public Health. 2022 Jul 14;19(14):8577. doi: 10.3390/ijerph19148577.
4
Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.上皮性卵巢癌：提供易感性基因的证据。
Int J Environ Res Public Health. 2022 Jul 1;19(13):8113. doi: 10.3390/ijerph19138113.
5
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era.蛋白质组学在卵巢癌中的应用：新时代的曙光。
Proteomes. 2022 May 9;10(2):16. doi: 10.3390/proteomes10020016.
6
Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer.雄激素受体基因通路上调与寡转移前列腺癌的放射抵抗
Int J Mol Sci. 2022 Apr 26;23(9):4786. doi: 10.3390/ijms23094786.
7
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.晚期前列腺癌患者的管理：2021 年晚期前列腺癌共识会议报告。
Eur Urol. 2022 Jul;82(1):115-141. doi: 10.1016/j.eururo.2022.04.002. Epub 2022 Apr 18.
8
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review.自噬与前列腺癌关系的新认识：全面综述
Int J Mol Sci. 2022 Mar 30;23(7):3826. doi: 10.3390/ijms23073826.
9
Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer.VPC-70619 的研发，一种小分子 N- Myc 抑制剂，有望成为神经内分泌前列腺癌的潜在疗法。
Int J Mol Sci. 2022 Feb 26;23(5):2588. doi: 10.3390/ijms23052588.
10
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.醋酸阿比特龙和泼尼松与或不与恩扎卢胺用于高危非转移性前列腺癌：来自 STAMPEDE 平台方案两项随机对照 3 期试验主要结果的荟萃分析。
Lancet. 2022 Jan 29;399(10323):447-460. doi: 10.1016/S0140-6736(21)02437-5. Epub 2021 Dec 23.
Zotero 插件